May 19th 2025
The study found differences in genomic alteration frequencies between non-Hispanic Black and non-Hispanic White veterans with metastatic prostate cancer, but showed similar survival outcomes.
How genomic testing and molecular markers are improving the landscape of advanced prostate cancer
December 13th 2021"I think that we have seen a lot of updates and advances in advanced prostate cancer generally, one of the biggest of these being PSMA-targeted lutetium," says Alicia K. Morgans, MD, MPH.